Literature DB >> 4079549

[Parkinsonism possibly caused by cinnarizine].

J F Martí Massó, N Carrera, E de la Puente.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4079549

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  7 in total

1.  Extrapyramidal and depressive side reactions with flunarizine and cinarizine.

Authors:  C A Mangone; E Herskovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

2.  Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.

Authors:  D Capellà; J R Laporte; J M Castel; C Tristán; A Cos; F J Morales-Olivas
Journal:  BMJ       Date:  1988-09-17

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Aggravation of Parkinson's disease by cinnarizine.

Authors:  J F Martí Massó; J A Obeso; N Carrera; J M Martínez-Lage
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

6.  Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.

Authors:  Kai-Ming Jhang; Jing-Yang Huang; Oswald Ndi Nfor; Yu-Chun Tung; Wen-Yuan Ku; Chun-Te Lee; Yung-Po Liaw
Journal:  Eur J Clin Pharmacol       Date:  2017-04-06       Impact factor: 2.953

7.  Flunarizine related movement disorders: a nationwide population-based study.

Authors:  Kai-Ming Jhang; Jing-Yang Huang; Oswald Ndi Nfor; Yu-Chun Tung; Wen-Yuan Ku; Cheng-Feng Jan; Yung-Po Liaw
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.